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Z IN C  C O N TEN T IN  T H E  S ER U M  A N D  C A R B O N IC  
A N H YD R A SE IN H IB IT IO N
Al. Stanchev, D. I. Dimitrov
It is well known that the activity of certain cellular enzymes is related 
to the presence of a zinc ion in their active center, and that metal bound to 
it accounts for inactivation of the enzyme (3, 7, 23, 24). The carbonic anhy- 
drase (CAH), the lactic acid-, alcoholic- and glutamate-dehydrogenase, 
carboxypeptidase etc. fall within the group of zinc-metal enzymes alluded to. 
As early as 1940 Keilin and Mann (10) demonstrated that CAH of the ery- 
trocytes contains 0.33% zinc, and moreover that the sulfonamides account 
for inhibition of its activity (10, 22, 23). A reversible inactivation of CAH is 
obtained under the effect of BAL, cyanides, sulfides, sulfonamides etc., all 
of them zinc bound (24). A rapid and intense exchange of zinc ions is observed 
between plasma and erythrocytes under physiological and pathological 
conditions alike (18). In 1950 Roblin and Clapp derived the acetazolamide 
which exerts a strong inhibitory effect upon the activity of CAH in the kidney 
and thus produces diuresis. The mechanism of acetazolamide inhibition of 
carbonic anhydrase is not thoroughly clarified. It is quite possible that it 
occurs through the zinc ion linkage to the active CAH center, but the other 
routes by which inactivation of the metal enzymes is generally accompli­
shed are not excluded (4). Nevertheless, it is beyond doubt that the activity 
of CAH is conditioned by its zinc link (13), and furthermore, that the diu­
retic effect of acetazolamide is secondary to CAH inhibition in the kidneys 
(2, 19, 22).
The goal of the present work is to prove exactly what is the influence of 
acetazolamide exerted upon the zinc in the serum and upon the zincuria 
in individuals treated with it. It is known that the hydrochlorthiacide 
(neodehydratin — ND) and chlorthalidone (saluretin — S) exert an insigni­
ficant effect on CAH in vitro compared with acetazolamide (dehydratin — D).
M aterial and Methods
A series of 23 patients underwent investigation. In 18 of them (group A) 
the zincemia was determined prior to receiving D and daily, over a period 
of 3 days, during which period the patients received 2x250 mg dehydratin 
per 24 hours. In 9 patients of this group the zincuria in the 24-hour urine was 
also determined. Four additional patients were investigated in the same 
fashion, undergoing immediately prior to the experiment a treatment with 
diuretics — with dehydratin — 2 cases, with neo-dehydratin — 1 and with
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saluretin — 1 (group B). One patient was also studied in whom neo-dehy- 
dratin was applied in doses of 50 mg per 24 hours.
The patients received in addition 2—3 gr potassium chloride, and those 
with cardiac insufficiency digitalis as well. Drugs influencing the metabolism 
of zinc were not administered.
The zinc was determined after the method of Wolf, with ditison, as modi­
fied by Rechenberger (17, 26, 27).
Results
In all the 18 patients of group A a decrease was established of the serum 
zincemia and increase of the zincuria in compairson to initial values. Zin- 
cemia was acutely lowered as early as receiving the first 500 mg D; in the 
following two days the decrease of zincemia was moderate. Occasionally, a 
sbustantial decrease of zincemia was also observed (Table 1). On the whole, 
the zincemia was decreased for the total number of cases in the average from 
144±23 y% to 96±19 y%, i. e. reaching evident hypozincemic concentra­
tions. In the 9 patients group zincuria was increased in the average from 
384±93 y% to 1029±481 y% for 24 hours.
The results are statistically reliable (Table 1).
In the four patients of group B, the zincemia was maintained unchanged, 
whereas the zincuria and diuresis were insignificantly raised and were sta­
tistically unreliable (Table 2). The zincemia in the patient treated with neo- 
dehydratin was unaltered. A strict parallelism between the decrease oi 
zincemia, raise of zincuria and diuresis in the patients receiving dehydratir. 
was not established. However, alterations in the zincemia and zincuria were 
recorded at the time when obvious increase of diuresis was produced by 
dehydratin, i. e. when its inhibitory effect upon the renal CAH was mani­
fested (Tables 1 and 2).
Discussion
The zinc in the serum is found in two forms: firmly bound zinc =  34% ol 
the total zinc, and unstably bound zinc, representing a metal protein complex 
— 66% (24). Under pathological conditions, the changes in zincemia occur 
at the expense of changes in the unstable fraction (8, 24). It could be assumed 
by analogy that the dehydratin, provided with a sulfonamide radical, binds 
part of the labile zinc, extracts it and emits it with urine. The increase 
of zincuria is a further support of a similar hypothesis.
Presumably, with blocking of renal CAH, occurring simultaneously 
with the above process, the kidney increases its permeability for the zinc 
ion in a fashion that zincemia appears to be the sequela of hyperzincuria 
induced by contemporaneous increasing of diuresis. Normally, scarcely 
2—3% of the alimentary zinc is separated in the urine (25), and the zincuria 
appears not to be dependent upon the 24-hour diuresis (9).
It is established that a major part of alimentary zinc is excreted via the 
intestines (6, 21, 20, 24).
Having established approximately a three-fold increase of zincuria under 
the effect of dehydratin, a quantity hardly exceeding 10% of the alimentary 
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Name history of 
illness No. Diagnosis
Zincemia
before Y % after
Zincuria
before
K. I. R. 4207 
31. 3. 65
Bronchitis cliron. Cor pulmonale. 
Emphysema pulm. Decomp. Ill 1 S -1 5 6
119
106—111.3
109 ? 0 3 - 529-5
D. A. A. 4626 
8. 4. 65
Bronchitis cliron. Cor pulm. 
Emphysema pulm. Myocardio- 




D. P. S. 4705 
10. 4. 65
Myocardiosclerosis atherosclerotica. 
Arrythmia absoiuta. Bronchitis chr. 
Emphysema pulm. Decomp. II





I. Y. S. 5420 
26. 4. 65
Vitium cordis. Insuf. et stenosis 





106 i95 5I45~ 1-5.5 Й 69- 337-5
E. N. Ch. 5468
24. 4 65
Myocardiosclerosis atherosclerotica. 
Decomp. Ill 136 148.5
122_] |g
116 119 421 !





*6 ' —169 177 lbJ
154
84 — 114.6 
106
t86 247 5 309 ^4/ '° ^








409_444 5480 44415 j
Statistical elaboration of results X±S144 + ±23y 96±19y 384±93y
Average error (of standard deviation) Sx 5.3 4.4 31
P according to ‘t ” criterium of Student P=0.1% P = <
d >D 48 >47.9 645 >
Zincemia and Zincuria Prior to and After receiving Dehydratiri Foil 




Zincemia y % Zincuria Y/2
before after before
H.N.R 5849 Vitium cordis, (insuf. sten. valv. * 157 5
145
129 138 3 rno—477.5
38
776. 5. 65 mitr.) Decomp 111 154 141 523 10
N.N.Z. 5947 Morbus hypertonicus 154 .c ,
145
129 1416 i l l —247.5
3C
241. b. 65 Cor hypertonicus. 1б7—161 151 37o 25Decomp. II
T.V.l. 6789 RhfMimatisniiis Vitium (stenosis 128 0 0 1 0 0 7 39
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food is resorbed), it is obvious that zincuria alone could not explain the 
prompt and substantial decrease of serai zinc.
The following mechanisms might be considered:
a) the dehydratin blocks zinc resorption in the intestines;
b) the dehydratin stimulates zinc excretion into the intestines and other 
organs, and in their secretions respectively.
Neither of the presumptions stated, however, could explain the rapid 
and substantial decrease of zinc in the serum and accordingly increase of 
zincuria.
c) It may be assumed that under the effect of dehydratin, directly or 
indirectly, through CAH inhibition in the erythrocytes of other cells, a re­
distribution of zinc takes place from the plasma towards some cellular ele­
ments. Under the aspect just outlined, it is of interest to trace out the chan­
ges in CAH and in the zinc content of erythrocytes prior to and after appli­
cation of dehydratin. Verification of the relative importance of these assum­
ptions is forthcoming.
The reduction of zincemia is not a sequela of digitalis and potassium 
chloride treatment, as a fall of zincemia level is also recorded in individuals 
not subjected to a similar treatment, and by virtue of the fact that digitalis 
treatment precedes the experiment with D etc.
The circumstance that zincuria rises as a result of the effect of a potent 
inhibitor exerted upon exclusively cellular enzyme, such as the CAH, for 
whose activity the zinc ion is essentially indispensable, proves that zincu- 
resis does not constitute an ordinary filtration process, but rather a process 
related to the function of cellular structures.
Our observation that zincemia and zincuria are not significantly changed, 
provided previous to the application of dehydratin the patients underwent 
treatment with some of the diuretics, is a further confirmation of this idea. 
Presumably, in these irstances the cells of the uriniferous tubules resist the 
increase of zincuria. Whether the causes for the reduction of diuresis during 
prolonged application of diuretics also exerts certain effect on the zinc 
secretion from the kidneys is a question yet unanswered. Furthemore, the 
serai zinc in the four patients, treated with diuretics previous to the appli­
cation of dehydratin, was retained unaltered. Two of them, previous to 
the acute experiment with dehydratin received also D. Very likely, during a 
prolonged treatment with dehydratin the organism puts on regulatory me 
chanisms which a) gradually restore normal zincemia and b) render the latter 
resistant to a new dehydratin block. Such a tendency is also marked in some 
patients as early as after the first day of application of dehydratin, being 
its initial dose the most efficient (Table 1, history of illness№4170, history 
of illness № 4705 etc.).
The negative result of the experiment with dehydratin in the two patients, 
previously treated with neo-dehydratin and saluretin, as well as in the single 
patient investigated with ND alone is quite indicative.
Most probably, the diuretics listed are not endowed with hypozincemi- 
zing effect. The latter fact is in accordance with their well known property, 
namely, that they do not inhibit the activity of CAH or they bring about 
merely an insignificant inhibition as compared to D, in vitro.
On the other hand, however, Pulver and assoc, suppose that the chlorthia- 
cide and chlorthalidone in vivo are split in powerful CAH inhibitors (16).
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If the latter holds true, it is likely that under the effect of their metabolites 
in the patients of our series treated previously with ND and S, changes 
might occur analogous to those achieved during prolonged treatment with 
dehydratin, substantiating the resistance to the acute D blow. Thus, an 
explanation of the changes observed in the serum zinc and zincuria might 
be found. We are not able to answer the question whether in this case a com- 
petetive effect is concerned on behalf of the diuretics discussed, or on behalf 
of their metabolites upon the dehydratin.
The interpretation of our results concerning the effect of dehydratin upon 
zincemia is in the sense that it brings about a reduction of serum zinc mainly 
through inhibiting the CAH in the kidneys with simultaneous diuresis and 
zincuria increase.
Our experiments did not furnish an answer to the question up to what 
extent does the CAH of erythrocytes and other tissues participate in the 
sense of zinc re-distribution between plasma and cells.
Inferences
1. Dehydratin applied in a dose 2x250 mg 24 hours for a duration of 
3 days, produces statistically reliable reduction of the pre\ iously normal zinc 
level in the serum.
2. A simultaneous raise of zincuria is also observed.
3. Individuals with a past history of diuretic treatment (neo-dehydratin, 
saluretin, dehydratin) do not reveal changes in the serum zinc and in zincu­
ria subsequent to charging with dehydratin in the doses indicated. It is 
probable that the organism is rendered resistant to a new dehydratin „blow“, 
after having overcomed by way of a proper regulatory route the originally pro­
duced by D hypozincemia.
Our observations on the occurrence of resistance after application of 
other diuretics (ND and S) are very limited and hence, a definitive conclu­
sion concerning the mechanism of their action is not warranted.
4. It is supposed that the effect of dehydratin on the metabolism of zinc 
is achieved through influencing the CAH activity, as changes in the serum 
zinc and zincuria are noted merely provided an increase of diuresis occurs 
under the effect of dehydratin which blocks the carbonic anhydrase.
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СОДЕРЖАНИЕ ЦИНКА B CbIBOPOTKE КРОВИ И ИНГИБИЦИЯ 
КАРБОАНГИДРАЗЬ!
Ал. Станчев, Д. Ив. Димитров 
РЕЗ ЮМЕ
Авторн находят, что после дачи дегидратина (ацетацоламид) — 2х 
250 мг 24 ч., в течение 3 дней у 18 больннх с показаниями для принятия 
зтого медикамента, наступает статистически достоверное снижение ко­
личества цинка в снворотке крови и у 9 исследованннх больннх — уве­
личение цинкурии. После обсуждения возможннх механизмов зтих из- 
менений, авторн толкуют полученнне результатн в смнсле, что дегидра- 
тин оказнвает гипоцннкемизирующий зффект путем подавления карбо- 
ангидразн в почках, но не исключают возможности соучастия карбоанги- 
дразн других тканей, соотв. таковой зритроцитов.
